ADAP
XNAS
$0.05
Adaptimmune Therapeutics plc American Depositary Shares (ADAP)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$87M
Revenue 5Y CAGR
+55.42%
Price Chart
Valuation
Market Cap$87M
P/S1.39
P/B-1.23
Profitability
Total Revenue (TTM)$62M
EBITDA-$149M
Profit Margin-260.8%
Operating Margin-221.5%
EPS-$0.11
Financial Health
Debt-to-Equity424%
Growth & Risk
Revenue 5Y CAGR+55.42%
Sharpe Ratio-0.21